Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
BridgeBio Pharma: Q2 Earnings Snapshot
By AP News - Aug 01, 2024, 11:06 AM ET
Last Updated - Aug 01, 2024, 11:06 AM EDT
PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $73.5 million in its second quarter.
The Palo Alto, California-based company said it had a loss of 39 cents per share. Losses, adjusted for non-recurring gains, were $1.02 per share.
Sponsored
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.09 per share.
The rare disease drug developer posted revenue of $2.2 million in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $8.3 million.
BridgeBio Pharma shares have decreased 36% since the beginning of the year. The stock has fallen 26% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BBIO at https://www.zacks.com/ap/BBIO
Sponsored
Read More from Investing
Popular News
Latest News
